Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

What Investors Think About Endo Pharmaceuticals
Motley Fool
Tuesday, August 3, 2010 - 6:59pm
tags:
Endo, investors
Drama Continues: What's Genzyme Worth to Sanofi?
Motley Fool
Tuesday, August 3, 2010 - 6:05pm
tags:
Sanofi, M&A, Genzyme
Cypress Biosciences up 22% in pre-market trading
Marketwatch
Tuesday, August 3, 2010 - 11:15am
tags:
Cypress Bioscience, Ramius, M&A
Cornerstone Therapeutics lands licensing deal with Targacept worth potential $75M
Bizjournals.com
Tuesday, August 3, 2010 - 11:10am
tags:
Targacept, licensing, Cornerstone Therapeutics
Pozen shares tumble on 2Q net, outlook
Bizjournals.com
Tuesday, August 3, 2010 - 11:08am
tags:
Pozen, earnings
Sanofi-Aventis Will Need to Raise Bid to Win Genzyme
WSJ Online
Tuesday, August 3, 2010 - 10:15am
tags:
GSK, JNJ, Genzyme, M&A, Sanofi
Pfizer: Will Earnings Beat Get the Shares Moving?
Seeking Alpha
Tuesday, August 3, 2010 - 10:13am
tags:
Pfizer, earnings
Trius Therapeutics prices shares of downsized IPO
CNBC
Tuesday, August 3, 2010 - 9:59am
tags:
IPOs, Trius Therapeutics
Adult stem cell therapies making rapid progress in human studies
Fierce Biotech Research
Tuesday, August 3, 2010 - 9:58am
tags:
stem cells, Geron
Diabetes drugs dispensed by NHS rockets 43% in five years
Pharma Times, UK
Tuesday, August 3, 2010 - 9:56am
tags:
UK, diabetes
Advisors tell Alcon shareholders to vote 'no' to Novartis slate
Pharma Times, UK
Tuesday, August 3, 2010 - 9:55am
tags:
Alcon, M&A, Novartis
Geron Posts Narrower Loss
Yahoo/Zacks.com
Tuesday, August 3, 2010 - 9:54am
tags:
Geron, earnings
Rigel posts 2Q net income on AstraZeneca payment
Yahoo/AP
Tuesday, August 3, 2010 - 9:53am
tags:
AstraZeneca, Rigel, earnings
Allergan CEO Says Company Isn't For Sale, Deal Would Be Tough
NASDAQ.com
Tuesday, August 3, 2010 - 8:52am
tags:
Allergan, Pharma CEOs, M&A, David Pyott
Neurocrine Biosciences is in outstanding position to build shareholder value
Yahoo/Zacks.com
Tuesday, August 3, 2010 - 8:49am
tags:
Neurocrine
Pfizer Wallops Profit, Sales Estimates
TheStreet.com
Tuesday, August 3, 2010 - 8:25am
tags:
Pfizer, earnings
Sanofi sends $69/share offer to Genzyme: sources
Yahoo/Reuters
Tuesday, August 3, 2010 - 8:22am
tags:
M&A, Sanofi, Genzyme, GSK, JNJ
Where Does the WuXi Deal Breakup Leave Charles River?
Seeking Alpha
Tuesday, August 3, 2010 - 8:19am
tags:
Charles River Laboratories, M&A, WuXi PharmaTech
Jazz Pharma - FDA Panel Prep
TheStreet.com
Tuesday, August 3, 2010 - 8:17am
tags:
FDA, advisory panels, Jazz Pharmaceuticals, fibromyalgia, JZP-6
Allergan's Botox Migraine Review Extended Three Months by U.S. Regulators
Bloomberg
Monday, August 2, 2010 - 8:34pm
tags:
Allergan, FDA, migraines, Botox

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.